Health X Platform (HEALTHX)₹275.10−1.33%Healthcare Service Provider
In the Jun 2026 quarter (consolidated), Health X Platform reported sales of ₹448 Cr, up 49.7% from Jun 2025, and net profit of ₹2 Cr, down 92.5% year on year. For the year to Mar 2026, sales were ₹1,324 Cr and net profit −₹1.01 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 360 | 376 | 307 | 271 | 274 | 282 | 287 | 299 | 302 | 347 | 375 | 448 |
| Expenses | 355 | 371 | 317 | 272 | 278 | 305 | 311 | 292 | 324 | 356 | 398 | 455 |
| Operating Profit | 3.38 | 3.42 | −10.66 | −2.41 | −4.71 | −23.71 | −25.21 | 6.07 | −22.60 | −10.35 | −25.20 | −8.37 |
| OPM % | 0.9% | 0.9% | −3.5% | −0.9% | −1.7% | −8.4% | −8.8% | 2.0% | −7.5% | −3.0% | −6.7% | −1.9% |
| Other Income | 9.73 | 20.18 | 18.49 | 28.82 | −168 | −14.09 | 21.96 | 25.44 | 5.35 | 13.66 | 12.83 | 12.86 |
| Interest | 0.23 | 0.23 | 0.26 | 0.09 | 0.05 | 0.04 | 0.00 | 0.08 | 0.03 | 0.16 | 0.48 | 0.58 |
| Depreciation | 2.19 | 2.30 | 2.52 | 1.60 | 1.44 | 1.42 | 1.33 | 1.16 | 1.32 | 2.16 | 1.93 | 1.88 |
| Profit before tax | 10.62 | 20.96 | 4.99 | 24.57 | −173 | −39.12 | −4.62 | 30.11 | −18.59 | 0.91 | −14.77 | 1.96 |
| Tax % | −23.0% | 3.9% | −583.0% | −102.8% | −13.2% | 2.0% | −478.5% | 11.9% | −17.2% | 59.8% | −12.5% | −0.5% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.99 | −189 | −0.99 | 0.00 | 0.00 | 0.00 | 0.00 | −0.99 | 0.00 |
| Net Profit | −12.19 | −3.22 | 21.57 | 40.98 | −155 | −37.81 | 17.56 | 26.60 | −15.45 | 0.38 | −12.98 | 2.00 |
| EPS (Rs) | −2.56 | −0.25 | 5.18 | 9.81 | −34.46 | −8.48 | 4.31 | 7.54 | −4.00 | 0.37 | −3.52 | 0.81 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 89.34 | 135 | 163 | 223 | 390 | 553 | 1,804 | 1,063 | 1,436 | 1,162 | 1,324 | 1,472 |
| Expenses | 116 | 155 | 175 | 255 | 440 | 561 | 683 | 1,167 | 1,456 | 1,176 | 1,369 | 1,533 |
| Operating Profit | −27.98 | −20.01 | −13.01 | −32.99 | −52.02 | −9.99 | 1,114 | −107 | −24.01 | −19.01 | −52.01 | −66.52 |
| OPM % | −31.0% | −15.0% | −8.0% | −15.0% | −13.0% | −1.9% | 62.0% | −10.0% | −1.7% | −1.6% | −4.0% | −4.5% |
| Other Income | 0.00 | 2.01 | 7.02 | 0.00 | 1.01 | 1.01 | 3.01 | −5.01 | 4.01 | −179 | 57.15 | 44.70 |
| Interest | 1.99 | 2.99 | 0.99 | 2.99 | 0.99 | 2.99 | 2.99 | 1.99 | 0.99 | 0.00 | 0.99 | 1.25 |
| Depreciation | 6.98 | 6.98 | 5.98 | 5.99 | 4.99 | 3.99 | 3.99 | 7.97 | 8.98 | 5.98 | 6.98 | 7.29 |
| Profit before tax | −36.88 | −27.93 | −11.96 | −41.86 | −57.87 | −15.94 | 1,105 | −122 | −29.91 | −203 | −1.99 | −30.49 |
| Tax % | −1.0% | 2.0% | 19.0% | 3.0% | −9.0% | 4.0% | 22.0% | −19.0% | −119.0% | −34.0% | −39.0% | — |
| Exceptional items | 0.00 | 1.99 | 6.99 | 0.00 | 0.00 | 0.00 | 912 | −6.99 | 0.00 | −182 | −0.99 | −0.99 |
| Net Profit | −36.98 | −29.01 | −14.99 | −43.01 | −51.97 | −17.01 | 865 | −98.99 | 5.99 | −134 | −1.01 | −26.05 |
| EPS (Rs) | −11.53 | −9.03 | −3.74 | −11.83 | −12.22 | −3.28 | 197.64 | −22.73 | 2.80 | −28.74 | 0.38 | −6.34 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 31.91 | 31.91 | 31.90 | 31.87 | 31.91 | 31.88 | 31.91 | 31.99 | 31.99 | 31.94 | 31.96 | 31.93 |
| Reserves | 223 | 186 | 163 | 144 | 111 | 178 | 168 | 796 | 723 | 731 | 639 | 610 |
| Borrowings | 5.01 | 19.03 | 21.02 | 12.01 | 2.01 | 8.01 | 12.02 | 2.01 | 9.03 | 4.01 | 1.01 | 26.06 |
| Other Liabilities | 21.89 | 19.90 | 35.00 | 48.07 | 86.04 | 98.14 | 80.16 | 451 | 443 | 385 | 301 | 270 |
| Total Liabilities | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,282 | 1,207 | 1,151 | 972 | 938 |
| Fixed Assets | 136 | 125 | 125 | 117 | 115 | 114 | 110 | 92.57 | 107 | 110 | 102 | 117 |
| CWIP | 3.01 | 0.00 | 0.00 | 1.01 | 1.01 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 10.03 | 1.01 |
| Investments | 22.04 | 10.03 | 17.05 | 46.08 | 36.12 | 56.16 | 43.10 | 668 | 514 | 678 | 577 | 520 |
| Other Assets | 119 | 121 | 110 | 71.25 | 77.34 | 146 | 140 | 520 | 585 | 364 | 284 | 300 |
| Inventories | 16.94 | 15.95 | 23.95 | 27.91 | 32.92 | 76.80 | 76.83 | 114 | 180 | 116 | 110 | 145 |
| Trade receivables | 12.04 | 8.02 | 19.07 | 4.01 | 8.03 | 15.06 | 14.04 | 21.07 | 35.11 | 35.11 | 10.04 | 8.03 |
| Cash & equivalents | 13.03 | 13.03 | 34.08 | 13.03 | 7.01 | 18.04 | 13.03 | 213 | 196 | 47.14 | 12.03 | 30.06 |
| Total Assets | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,282 | 1,207 | 1,151 | 972 | 938 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −12.04 | −12.02 | −2.01 | −49.12 | −30.10 | −69.21 | −31.07 | −207 | −112 | 36.08 | −17.05 | −74.20 |
| Cash from investing activity | 6.98 | −0.99 | 3.99 | 14.96 | −1.99 | −21.94 | 20.93 | 219 | 133 | −33.93 | −0.99 | 170 |
| Cash from financing activity | 4.01 | 13.04 | 5.01 | 33.10 | 26.06 | 103 | 4.01 | −11.02 | −2.01 | −2.01 | 0.00 | −80.16 |
| Net cash flow | −1.01 | 0.00 | 7.02 | −2.01 | −6.02 | 11.05 | −5.02 | 1.01 | 19.07 | 0.00 | −19.05 | 18.06 |
| Capex | 18.06 | 8.02 | 2.01 | 6.02 | 3.01 | 2.01 | 1.01 | 5.02 | 19.04 | 14.03 | 10.03 | 15.03 |
| Free cash flow | −28.03 | −18.04 | 0.00 | −55.11 | −33.07 | −71.14 | −31.05 | −212 | −128 | 22.03 | −27.05 | −89.12 |
| CFO / OP % | 106.0% | 43.0% | 17.0% | 377.0% | 89.0% | 133.0% | 288.0% | −8.0% | 104.1% | −172.0% | 68.0% | 133.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 87 | 34 | 52 | 9 | 13 | 14 | 9 | 4 | 12 | 9 | 3 | 2 |
| Inventory days | 337 | 91 | 80 | 73 | 59 | 77 | 57 | 71 | 69 | 34 | 40 | 44 |
| Days payable | 164 | 37 | 68 | 23 | 25 | 49 | 28 | 20 | 21 | 12 | 20 | 25 |
| Cash conversion cycle | 258 | 86 | 61 | 57 | 45 | 40 | 37 | 54 | 58 | 30 | 21 | 19 |
| Working capital days | 344 | 182 | 49 | 61 | 61 | 54 | 44 | 46 | 93 | 58 | 47 | 16 |
| ROCE % | −6.0% | −14.0% | −11.9% | −8.0% | −19.0% | −25.0% | −6.0% | −7.0% | −11.0% | −3.0% | −1.0% | 0.0% |
For the Jun 2026 quarter, Health X Platform reported sales of ₹448 Cr, up 49.7% year on year and net profit of ₹2 Cr, down 92.5% year on year. The operating margin was −1.9%.
Health X Platform's sales for the year to Mar 2026 were ₹1,324 Cr; over the last twelve months they were ₹1,472 Cr.
Net profit for the year to Mar 2026 was −₹1.01 Cr, and −₹26.05 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−6.34.
Health X Platform reported borrowings of ₹26.06 Cr at Mar 2026, against cash and equivalents of ₹30.06 Cr.
Cash from operations was −₹74.20 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹89.12 Cr.